1921
Volume 88, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Despite the availability of many methods for rapid and early diagnosis of dengue, there is still a need to develop new approaches that not only combine low cost, specificity, and sensitivity, but also are capable of accurately detecting secondary infection in the early stages of the disease. We report the potential of the high mobility group box 1 protein as an auxiliary biomarker for early dengue diagnosis. We tested a 205-sample serum panel that included negative and positive samples from primary and secondary dengue cases, as well as samples from patients with dengue-like symptoms. We observed that high mobility group box 1 protein was generally detected only in dengue-positive samples for persons with primary and secondary infections. These results highlight the possibility of using this endogenous molecule as an auxiliary biomarker to aid in dengue detection and improve current methods for early diagnosis of dengue.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.12-0619
2013-03-06
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/88/3/506.html?itemId=/content/journals/10.4269/ajtmh.2012.12-0619&mimeType=html&fmt=ahah

References

  1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martínez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW, , 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8: S7S16.[Crossref]
  2. Simmons CP, Farrar JJ, Nguyen V, Wills B, , 2012. Dengue. N Engl J Med 366: 14231432.[Crossref]
  3. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, Enria DA, Farrar J, Gubler DJ, Guzman MG, Halstead SB, Hunsperger E, Kliks S, Margolis HS, Nathanson CM, Nguyen VC, Rizzo N, Vázquez S, Yoksan S, , 2010. Evaluation of diagnostic tests: dengue. Nat Rev Microbiol 8: S30S38.[Crossref]
  4. Bianchi ME, Manfredi AA, , 2007. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 20: 3536.[Crossref]
  5. Muller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A, Beltrame M, Bianchi ME, , 2001. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 20: 43374340.[Crossref]
  6. Scaffidi P, Misteli T, Bianchi ME, , 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191195.[Crossref]
  7. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, Arnold B, Bianchi ME, Manfredi AA, Rovere-Querini P, , 2005. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174: 75067515.[Crossref]
  8. Huang W, Tang Y, Li L, , 2010. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51: 119126.[Crossref]
  9. Chen LC, Yeh TM, Wu HM, Lin YY, Shyu HW, , 2008. Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. J Infect 56: 143150.[Crossref]
  10. Kamau E, Takhampunya R, Li T, Kelly E, Peachman KK, Lynch JA, Sun P, Palmer DR, , 2009. Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication. J Gen Virol 90: 18271835.[Crossref]
  11. Allonso D, Belgrano FS, Calzada N, Guzman MG, Vazquez S, Mohana-Borges R, , 2012. Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection. J Clin Virol 55: 214219.[Crossref]
  12. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ, , 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248251.[Crossref]
  13. Andersson U, Tracey KJ, , 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139162.[Crossref]
  14. Nowak P, Barqasho B, Sonnerberg A, , 2007. Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection. AIDS 21: 869871.[Crossref]
  15. Torii Y, Ohta R, Imai M, Hara S, Kawano Y, Matsubayashi T, Inui A, Yoshikawa T, Nishimura N, Ozaki T, Morishima T, Kimura H, , 2011. Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children. Cytokine 56: 180187.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.12-0619
Loading
/content/journals/10.4269/ajtmh.2012.12-0619
Loading

Data & Media loading...

  • Received : 07 Oct 2012
  • Accepted : 25 Nov 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error